Regulation of cGMP synthesis in cultured podocytes by vasoactive hormones

Journal of Physiology and Pharmacology

Volumn 57, Issue 4, 2006, Pages 599-610

  Lewko, Barbara ^a,b   Golos M ^a   Latawiec, E ^a   Angielski, S ^a,b   Stepinski, J ^a,b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Angiotensin II; cGMP; Guanylyl cyclases; Natriuretic peptides; Nitric oxide; Rat podocytes

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; CHELERYTHRINE; CYCLIC GMP; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROBENECID; SARALASIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; NONHUMAN; PODOCYTE; RADIOIMMUNOASSAY; RAT;

ANGIOTENSIN II; ANIMALS; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; CYCLIC GMP; IMIDAZOLES; NITRIC OXIDE DONORS; PODOCYTES; PYRIDINES; RADIOIMMUNOASSAY; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; S-NITROSO-N-ACETYLPENICILLAMINE; SARALASIN;

EID: 33846245021     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Lewko B, Wendt U, Stȩpiński J, Angielski S. Dexamethasone sensitizes soluble guanylyl cyclase in the rat renal glomeruli. Biochern Biophys Res Commun 1993;197:826-832.
2. Lewko B, Wendt U, Szczepanska-Konkel M, Stepinski J, Drewnowska K, Angielski S. Inhibition of endogenous nitric oxide synthesis activates particulate guanylyl cyclase in the rat renal glomeruli. Kidney Int 1997;52:654-659.
3. Stepinski J, Wendt U, Lewko B, Angielski S: Cooperation of particulate and soluble guanylyl cyclase systems in the rat renal glomeruli. J Physiol Pharmacol 2000;51:497-511.
4. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003;83:253-307.
5. Kriz W, Elger M, Mundel P, Lemley KV. Structure-stabilizing forces in the glomerular tuft. J Am Soc Nephrol 1995;5:1731-1739.
6. Drenckhahn D, Franke R-P. Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat and man. Lab Invest 1988;59:673-682.
7. Kawaguchi S, Uchida K, Ito T, Kozuka M, Shimonaka M, Mizuno T et al. Immunohistochemical localization of atrial natriuretic peptide receptor in bovine kidney and lung. J Histochem Cytochem 1989;37:1739-1742.
8. Zhao J, Ardaillou N, Lu CY, Placier S, Pham P, Badre L et al. Characterization of C-type natiuretic peptide receptors in human mesangial cells. Kidney Int 1994;46:717-725.
9. Mundel P, Gilbert P, Kriz W. Podocytes in glomerulus of rat kidney express a characteristic 44 KD protein. J Histochem Cytochem 1991;39:1047-56.
10. Sharma R, Lovell HB, Wiegmann TB, Savin VJ. Vasoactive substances induce cytoskeletal changes in cultured rat glomerular epithelial cells. J Am Soc Nephrol 1992;3:1131-1138.
11. Wang L, Flannery PJ, Spurney RF. Characterization of angiotensin II-receptor subtypes in podocytes. J Lab Clin Med 2003;142:313-321.
12. Liebau MC, Lang D, Bohm J, Endlich N, Bek MJ, Witherden I et al. Functional expression of the renin angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006;290:710-719.
13. Lai KN, Leung JC, Yandle TG, Fisher S, Nicholls MG. Gene expression and synthesis of natriuretic peptides by cultured human glomerular cells. J Hypertens 1999;17:575-583.
14. Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, Mundel P et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004;65:30-39.
15. Wang L, Fields TA, Pazmino K, Dai Q, Burchette JL, Howell DN et al. Activation of Galphaq-coupled signaling pathways in glomerular podocytes promotes renal injury. J Am Soc Nephrol 2005;16:3611-3622.
16. Patzak A, Lai E, Persson PB, Persson AE. Angiotensin II-nitric oxide interaction in glomerular arterioles. Clin Exp Pharmacol Physiol 2005;32:410-414.
17. Soualmia H, Barthelemy C, Masson F, Maistre G, Eurin J, Carayon A. Angiotensin II-induced phosphoinositide production and atrial natriuretic peptide release in rat atrial tissue. J Cardiovasc Pharmacol 1997;29:605-611.
18. Gauquelin G, Schiffrin EL, Garcia R. Downregulation of glomerular and vascular atrial natriuretic factor receptor subtypes by angiotensin II. J Hypertens 1991;9:1151-1160.
19. Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem 1994;269:11628-11633.
20. Caputo L, Benessiano J, Boulanger CM, Levy BI. Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery. Arterioscler Thromb Vasc Biol 1995;15:1646-1651.
21. Zhang C, Mayeux PR. Angiotensin II signaling activates the NO-cGMP pathway in rat proximal tubules. Life Sci 1998;63:PL75-80.
22. Haneda M, Kikkawa R, Maeda S, Togawa M, Koya D, Horide N et al. Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Kidney Int 1991;40:188-194
23. Kim D, Aizawa T, Wei H, Pi X, Rybalkin SD, Berk BC et al. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling. J Mol Cell Cardiol 2005;38:175-184.
24. Golos M, Lewko B, Bryl E, Witkowski JM, Dubaniewicz A, Olszewska A et al. Effect of angiotensin II on ANP-dependent guanylyl cyclase activity in cultured mouse and rat podocytes. Kidney Blood Press Res 2002;25:296-302.
25. Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B. Nuclear localization of the protein encoded by the Wilm's tumor gene WT1 in embryonic and adult tissues. Development 1993;119:1329-1341.
26. Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attie T et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 2002;160:131-139.
27. Mundel P, Gilbert P, Kriz W. Podocytes in glomerulus of rat kidney express a characteristic 44 kD protein. J Histochem Cytochem 1991;39:1047-1056.
28. Bergmeyer HU. Methods of enzymatic analysis. Academic Press, New York and London: 1974;480-481.
29. Steiner AL, Parker CW, Kipnis DM. Radioimmunoassay for cyclic nucleotides. J Biol Chem 1972;247:1106-1113.
30. Zor T, Selinger Z. Linearization of the Bradford protein assay increases its sensitivity: Theoretical and experimental studies. Anal Biochem 1996;236:302-308.
31. Sager G. Cyclic GMP transporters. Neurochem Int 2004;45:865-873.
32. Yan C, Kim D, Aizawa T, Berk BC. Functional interplay between angiotensin II and nitric oxide. Cyclic GMP as a key mediator. Artherioscler Thromb Vasc Biol 2003;23:26-36.
33. Ardaillou N, Placier S, Wahbe F, Ronco P, Ardaillou R. Release of cyclic nucleotides from the apical and basolateral poles of cultured human glomerular epithelial cells. Exp Nephrol 1993;1:253-260.
34. Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol 2003;139:1289-1296.
35. Crane JK, Shanks KL. Phosphorylation and activation of the intestinal guanylyl cyclase receptor for Escherichia coli heat-stable toxin by protein kinase C. Mol Cell Biochem 1996;165:111-120.
36. Potter LR, Hunters T. Activation of protein kinase C stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue. J Biol Chem 200;275:31099-31106.
37. Summers C, Myers LM. Angiotensin II decreases cGMP levels in neuronal cultures from rat brain. Am J Physiol 1991;260:C79-C87.
38. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-1412.
39. Inagami T, Eguchi S, Numaguchi K, Motley ED, Tang H, Matsumoto T et al. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases. J Am Soc Nephrol 1999;10:S57-S61.
40. Siragy HM. AT1 and AT2 receptor in the kidney: role in health and disease. Semin Nephrol 2004;24:93-100.